Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London PressReach · Jun 30, 2025
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines PressReach · Jun 29, 2025
HEPA Filters Market to Reach $5.8 Billion by 2032, Growing at a CAGR of 7.9% from 2025, Says Meticulous Research® PressReach · Jun 28, 2025
Ophthalmology Drugs Market worth $26.28 billion by 2030 with 6.1% CAGR | MarketsandMarkets™ PressReach · Jun 28, 2025
AARP Commits Thousands of Dollars to Strengthen 5 Communities Across Mississippi PressReach · Jun 27, 2025
Drug-Free Nasal Spray LUCA V-Defense Creates a Protective Shield Against Viruses and Allergies PressReach · Jun 27, 2025
Innovent Announces Mazdutide, First Dual GCG/GLP-1 Receptor Agonist, Received Approval from China's NMPA for Chronic Weight Management PressReach · Jun 27, 2025
GreenShield Expands Essential Medicines Program Across Canada to Bridge Gaps in Drug Coverage for Underserved Canadians PressReach · Jun 26, 2025
BioCity's ETA-Selective Antagonist SC0062 Granted Breakthrough Therapy Designation in China for Diabetic Kidney Disease with Albuminuria PressReach · Jun 26, 2025
